AA Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.18M Buy
4,512
+380
+9% +$97.4K 0.14% 110
2026
Q2
$1.04M Buy
4,132
+108
+3% +$23.2K 0.13% 109
2026
Q1
$875K Buy
4,024
+407
+11% +$90.3K 0.12% 117
2025
Q4
$827K Buy
3,617
+959
+36% +$218K 0.15% 101
2025
Q3
$615K Sell
2,658
-864
-25% -$176K 0.12% 104
2025
Q2
$654K Sell
3,522
-899
-20% -$167K 0.14% 91
2025
Q1
$926K Sell
4,421
-621
-12% -$121K 0.23% 73
2024
Q4
$896K Sell
5,042
-91
-2% -$16.7K 0.24% 71
2024
Q3
$1.01M Sell
5,133
-100
-2% -$18.7K 0.29% 67
2024
Q2
$898K Buy
5,233
+809
+18% +$134K 0.32% 67
2024
Q1
$806K Buy
+4,424
New +$762K 0.33% 72

Other funds holding ABBV

AA Financial Advisors's ABBV Position: Q3 2026 in Review

AA Financial Advisors increased its AbbVie (ABBV) stake by 9.2% in Q3 2026, buying an estimated $97.4K and bringing the position to 4,512 shares worth $1.18M. The position accounts for 0.14% of the portfolio, ranked #110.

AA Financial Advisors first reported a position in ABBV in Q1 2024 and has held it in 11 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • AA Financial Advisors held 4,512 shares of AbbVie worth $1.18M as of Q3 2026.
  • AA Financial Advisors bought 380 AbbVie shares in Q3 2026, an estimated $97.4K.
  • AbbVie made up 0.14% of AA Financial Advisors's portfolio in Q3 2026, its #110 holding.
  • AA Financial Advisors first reported a position in AbbVie in Q1 2024 and has held it in 11 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on AA Financial Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.